Neurology Day 2026
Agenda
| Time | Session | Location |
|---|---|---|
| 3:00 PM | Check-In | Atrium |
| 3:15 – 3:20 PM | Welcome Dr. Ian Shih, Vice Chair of Research |
Dogwood AB |
| 3:20 – 3:50 PM | Oral Presentations | Dogwood AB |
| Resident Research “Recognizing EEG Lead Swap Errors: Patterns and Prevention Strategies” Dr. Faris Almubaslat |
||
| Clinical Science “Wearable Ultrasound-Informed Data-Driven Modeling of Exoskeleton-Assisted Walking” Dr. Krysten Lambeth |
||
| Basic Science “A high-content microscopy screen identifies a class of environmental toxicants inducing TDP-43 pathology” Dr. Giulia Fragola |
||
| 3:55 – 4:55 PM | Poster Session A | Atrium |
| 5:00 – 6:00 PM | Keynote Presentation Dr. Alison Goate, Professor & Chair of Geriatrics and Genomic Science at the Icahn School of Medicine, Mount Sinai |
Dogwood AB |
| 6:00 – 7:00 PM | Poster Session B | Atrium |
| 7:00 PM | Closing Remarks |
Abstracts
Speakers
Alison Goate, D.Phil.
Professor & Chair, Genetics and Genomic Science at Mount Sinai
Dr. Goate is an internationally recognized leader in the genetics of neurodegenerative diseases and serves as the Jean C. and James W. Crystal Professor of Genomics and Chair of the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai.
For more than three decades, Dr. Goate has been at the forefront of Alzheimer’s disease (AD) and Frontotemporal Dementia (FTD) research. She was part of the team that discovered the first mutation causing familial Alzheimer’s disease and contributed to identifying major genetic variants for both AD and FTD, including Trem2 and MAPT mutations. Her work has helped shape current understanding of how microglial biology and genetic risk factors contribute to disease. Today, her lab uses cutting‑edge genome‑editing technologies to uncover disease mechanisms and advance therapeutic development.
Dr. Goate is also the founding director of Mount Sinai’s Ronald M. Loeb Center for Alzheimer’s Disease and has received some of the field’s highest honors, including the Potamkin Award, the Rainwater Prize, the MetLife Award, and the Alzheimer’s Association’s Lifetime Achievement Award. She is an elected fellow of both the American Association for the Advancement of Science and the National Academy of Medicine.
Dr. Faris Almubaslat
Dr. Almubaslat is a PGY3 Adult Neurology Resident. He received is Doctorate of Medicine from the University of North Carolina at Chapel Hill School of Medicine. As a resident, Dr. Almubaslat has been named Diagnostician of the month for two exceptional neurologic diagnosis. First he detected a Hoffman’s sign which led to the diagnosis of motor neuron disease, and secondly, he identified an internuclear ophthalmoplegia (INO) that had been missed on initial imaging, ultimately revealing a pontine stroke.
Dr. Krysten Lambeth
Dr. Lambeth is a post-doctoral researcher at UNC Neurology, working along side Dr. Irena Dujmovic. She graduated from Salem College in 2019 with a B.S. in Mathematics and received her Ph.D. in Biomedical Engineering from the Lampe Joint Department of Biomedical Engineering at UNC and NC State. Previously, Dr. Lambeth worked in Dr. Nitin Sharma’s lab, where her research is focused on synergy-inspired control of walking with a hybrid exoskeleton.
Dr. Giulia Fragola
Dr. Fragola earned an M.S. in Molecular Biology from the Università degli Studi di Milano-Bicocca and a Ph.D. from the European School of Molecular Medicine, where she studied the role of Polycomb proteins in transcription factor–induced somatic reprogramming under the mentorship of Dr. Stefano Casola and Dr. Giuseppe Testa. Dr. Fragola subsequently joined Dr. Zylka’s laboratory at the University of North Carolina at Chapel Hill, investigating the role of Topoisomerase 1 in maintaining genomic stability in the central nervous system. Currently, in Dr. Cohen’s research group, her work focuses on the role of DNA damage in neurodegeneration.